WNT3 and neoplasm: EC is characterized by elevated expression of multiple Wnt ligands (notably Wnt2, Wnt3, Wnt5A, and Wnt6) and FZD receptors, often correlating with poorer differentiation, higher potential of tumor invasion, and shorter survival.